自体输血临床路径管理专家共识(2019)

2019-02-10 中国输血协会 临床血液学杂志.2019.32(2):81-86.

对预存式自体输血、急性等容性血液稀释及回收式自体输血进行临床路径管理,分别确定3种自体输血的适应证、采血方案、回输方案及输血不良反应的诊治要点,从而推动自体输血的规范开展,提高患者血液管理水平。

中文标题:

自体输血临床路径管理专家共识(2019)

发布机构:

中国输血协会

发布日期:

2019-02-10

简要介绍:

对预存式自体输血、急性等容性血液稀释及回收式自体输血进行临床路径管理,分别确定3种自体输血的适应证、采血方案、回输方案及输血不良反应的诊治要点,从而推动自体输血的规范开展,提高患者血液管理水平。 

拓展指南:输血相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=自体输血临床路径管理专家共识(2019))] GetToolGuiderByIdResponse(projectId=1, id=6eebe1c001e076f0, title=自体输血临床路径管理专家共识(2019), enTitle=, guiderFrom=临床血液学杂志.2019.32(2):81-86., authorId=null, author=, summary=对预存式自体输血、急性等容性血液稀释及回收式自体输血进行临床路径管理,分别确定3种自体输血的适应证、采血方案、回输方案及输血不良反应的诊治要点,从而推动自体输血的规范开展,提高患者血液管理水平。 , cover=, journalId=null, articlesId=null, associationId=1014, associationName=中国输血协会, associationIntro=null, copyright=0, guiderPublishedTime=Sun Feb 10 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>对预存式自体输血、急性等容性血液稀释及回收式自体输血进行临床路径管理,分别确定3种自体输血的适应证、采血方案、回输方案及输血不良反应的诊治要点,从而推动自体输血的规范开展,提高患者血液管理水平。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>输血</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=2e5881c001688e95" title="儿童非输血依赖型地中海贫血的诊治和管理专家共识" target=_blank>儿童非输血依赖型地中海贫血的诊治和管理专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=f95081c0016e82bf" title="非输血依赖型地中海贫血诊断与治疗中国专家共识(2018年版)" target=_blank>非输血依赖型地中海贫血诊断与治疗中国专家共识(2018年版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=b4fb11c0016395ff" title="2018 儿科重症监护输血和贫血专家倡议:儿童重症患者红细胞输注建议" target=_blank>2018 儿科重症监护输血和贫血专家倡议:儿童重症患者红细胞输注建议</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=27c601c0013ea4f3" title="2016 BCSH指南:胎儿,新生儿以及年长儿童输血" target=_blank>2016 BCSH指南:胎儿,新生儿以及年长儿童输血</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=794411c00130510e" title="2015 NICE指南:输血(NG.24)" target=_blank>2015 NICE指南:输血(NG.24)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E8%BE%93%E8%A1%80" target=_blank>有关输血更多指南</a></ul>, tagList=[TagDto(tagId=68231, tagName=自体输血), TagDto(tagId=1012, tagName=临床路径)], categoryList=[CategoryDto(categoryId=69, categoryName=检验, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=21980, appHits=339, showAppHits=0, pcHits=12235, showPcHits=12619, likes=107, shares=15, comments=3, approvalStatus=1, publishedTime=Wed Feb 27 22:15:15 CST 2019, publishedTimeString=2019-02-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Feb 27 22:15:15 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 19:14:54 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=自体输血临床路径管理专家共识(2019))])
自体输血临床路径管理专家共识(2019)
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1065200, encodeId=d4ca106520022, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57c1539116, createdName=sunny-sasaj, createdTime=Sat Oct 30 08:46:21 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922064, encodeId=f6239220648f, content=需要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36465457931, createdName=ms7000000827997023, createdTime=Mon Feb 01 22:44:03 CST 2021, time=2021-02-01, status=1, ipAttribution=)]
    2021-10-30 sunny-sasaj

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1065200, encodeId=d4ca106520022, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57c1539116, createdName=sunny-sasaj, createdTime=Sat Oct 30 08:46:21 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922064, encodeId=f6239220648f, content=需要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36465457931, createdName=ms7000000827997023, createdTime=Mon Feb 01 22:44:03 CST 2021, time=2021-02-01, status=1, ipAttribution=)]
    2021-02-01 ms7000000827997023

    需要积分

    0